Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

Marder SR, Conley R, Ereshefsky L, Kane JM, Turner MS.

J Clin Psychiatry. 2003;64 Suppl 16:41-6. No abstract available.

3.
4.

Antipsychotic medication in the treatment of schizophrenia.

Kane JM.

Isr J Psychiatry Relat Sci. 1995;32(1):30-7. Review.

PMID:
7542642
5.

Clinical review of a long-acting, injectable formulation of risperidone.

Knox ED, Stimmel GL.

Clin Ther. 2004 Dec;26(12):1994-2002. Review.

PMID:
15823763
6.

Long-acting injectable risperidone.

Ehret MJ, Fuller MA.

Ann Pharmacother. 2004 Dec;38(12):2122-7. Epub 2004 Nov 2. Review. Erratum in: Ann Pharmacother. 2005 Jan;39(1):201.

PMID:
15522979
7.

Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.

Keith S.

Expert Rev Neurother. 2009 Jan;9(1):9-31. doi: 10.1586/14737175.9.1.9. Review.

PMID:
19102665
8.

[The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].

Faludi G.

Neuropsychopharmacol Hung. 2005 Mar;7(1):22-7. Review. Hungarian.

PMID:
16167464
9.

Schizophrenia: recent advances in psychopharmacology.

Sharma T.

Br J Hosp Med. 1996 Feb 21-Mar 5;55(4):194-8. Review. No abstract available.

PMID:
8777500
10.
12.

Antipsychotic dosing strategies in acute schizophrenia.

Janicak PG, Davis JM.

Int Clin Psychopharmacol. 1996 May;11 Suppl 2:35-40. Review.

PMID:
8803658
13.

[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].

Buis C, Gourion D, Vaiva G.

Encephale. 2009 Jan;Suppl 3:S91-5. doi: 10.1016/S0013-7006(09)75543-5. French. No abstract available.

PMID:
19268185
14.

[Pharmacoeconomic review of the use of injectable long-acting risperidone].

Bartkó G, Fehér L.

Neuropsychopharmacol Hung. 2005 Dec;7(4):199-207. Review. Hungarian.

PMID:
16496485
15.

[Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].

Dassa D, Lacambre M, Vacheron MN.

Encephale. 2009 Jan;Suppl 3:S109-13. doi: 10.1016/S0013-7006(09)75546-0. French. No abstract available.

PMID:
19268179
16.
17.

Strategies for dosing and switching antipsychotics for optimal clinical management.

Buckley PF, Correll CU.

J Clin Psychiatry. 2008;69 Suppl 1:4-17. Review.

18.

The case for long-acting antipsychotic agents in the post-CATIE era.

Nasrallah HA.

Acta Psychiatr Scand. 2007 Apr;115(4):260-7. Review.

PMID:
17355516
19.

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia.

Bhanji NH, Chouinard G, Margolese HC.

Eur Neuropsychopharmacol. 2004 Mar;14(2):87-92. Review.

PMID:
15013023
20.

[Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia].

Fujii Y.

Seishin Shinkeigaku Zasshi. 2001;103(12):1030-5. Review. Japanese. No abstract available.

PMID:
11925840

Supplemental Content

Support Center